Research Paper Volume 15, Issue 17 pp 8744—8769
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Figure 11. Expression of CLCN4 in the UCEC patients. (A, B) Immunohistochemical analysis of CLCN4 expression in normal endometrial tissues, an original magnification 40x, B original magnification 100x. (C, D) Immunohistochemical analysis of CLCN4 expression in the tumor tissues of UCEC patients, C original magnification 40x, D original magnification 100x.